Related Experiment Video

Updated: Aug 10, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

Detection of immunoglobulin light-chain mRNA in lymphoid tissues using a practical in situ hybridization method

L M Weiss1, L A Movahed, Y Y Chen

  • 1James Irvine Center, City of Hope National Medical Center, Duarte, CA 91010.

The American Journal of Pathology
|October 1, 1990
PubMed

Insights

This study introduces a new in situ hybridization method to detect light-chain mRNA in formalin-fixed tissues, improving immunoglobulin identification in lymphoid tissues and multiple myeloma.

Area of Science:

  • Molecular Biology
  • Pathology
  • Immunology

Background:

  • Immunoglobulin protein identification in fixed tissues is challenging with standard methods.
  • Existing techniques like immunoperoxidase have limitations in formalin-fixed, paraffin-embedded samples.

Purpose of the Study:

  • To develop and validate an in situ hybridization (ISH) method for identifying light-chain mRNA.
  • To apply this ISH technique to formalin-fixed, paraffin-embedded tissues for improved immunoglobulin detection.

Main Methods:

  • Developed an ISH methodology using radiolabeled or biotinylated oligonucleotide probes.
  • Probes targeted kappa and lambda light-chain gene-constant regions.
  • Applied the method to formalin-fixed, paraffin-embedded lymphoid tissues and lymphomas.

Main Results:

  • Consistently identified reactive plasma cells in lymphoid tissues.
  • Detected a monotypic pattern of light-chain mRNA restriction in multiple myeloma/plasmacytoma cases.
  • Detected light-chain mRNA in 30% of non-Hodgkin's lymphomas using radiolabeled probes and 19% using biotinylated probes.

Conclusions:

  • The developed ISH method is effective for identifying light-chain mRNA in formalin-fixed, paraffin-embedded tissues.
  • This technique aids in the diagnosis of lymphoid disorders, including multiple myeloma and non-Hodgkin's lymphomas.
  • ISH offers a valuable alternative or adjunct to protein-based methods for immunoglobulin analysis.

More Related Videos

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

FISH - Fluorescent In-situ Hybridization02:07

FISH - Fluorescent In-situ Hybridization

Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
In-situ Hybridization02:31

In-situ Hybridization

In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...